New research predicts a positive future for biosimilars

The prospect of reducing treatment costs for payors supports a positive future for biosimilars Biosimilar approvals in the US market still significantly lag behind Europe despite an evolving regulatory landscape and three new...

Hope in the treatment of kidney disease

Research into kidney disease is offering hope for sufferers in the years to come. One piece of research by a Kidney Research UK-funded scientist has made some vital advances in helping to understand a virus...

The hidden way to fill vacancies, train and retain

The BSc (Hons) Biomedical Science (pathology lab based) degree apprenticeship has been developed through consultation with pathology laboratory employers and is co-delivered, meeting the requirements for a Healthcare Science Practitioner (Biomedical Scientist) apprenticeship. The programme...

Aiming high and encouraging young people into the world of science

Talk to anyone in the bioscience world and they will tell you that one of their major concerns is the dearth of young people coming out of schools, colleges and universities having studied science...

UK-led study marks shift towards genetic era in tackling TB

In a landmark study that may herald a quicker, more tailored treatment for the millions of people around the world living with tuberculosis (TB), UK researchers have shown how our understanding of TB’s genetic...

Organ functions of the human yolk sac revealed

The role of the human yolk sac in supporting early embryonic development and the first wave of the prenatal immune system has been mapped in a study published in Science. Researchers from the Wellcome Sanger...

IBM releases novel AI-powered technology to accelerate medical research for COVID-19

IBM has today released a new set of cloud- and AI-powered technologies to help researchers, doctors and scientists accelerate COVID-19 drug discovery. These novel resources, from across IBM and available beginning today (Friday 3 April)...

Shanks v Unilever – An opening of the claim floodgates?

Varuni Paranavitane, IP Solicitor,  AA Thornton At the end of last year Professor Shanks was awarded £2 million for an invention relating to a glucose sensor made while employed working for Unilever.  What does this mean...

Targeting the right treatment at the right patient

One of the rapidly growing concerns in medicine is the anxiety that a lot of drugs do not work for a large number of the patients for whom they are prescribed. By Frances Griss Finding the...

Euro biotech: breaking down the barriers to a golden age

Converting cutting-edge research into viable products remains a challenge for the European biotech sector. Jonathan Hay of Delin Ventures investigates how ambition can translate to reality. Europe’s tech sector is going from strength to strength....

The Goldilocks Effect

Advances in the delivery of precision medicine trials in the UK have sparked interest in the commercial world. The concept of precision medicine is not new, but generating the scientific evidence to drive the concept...

Neurons are caught rapidly switching gears

A new study suggests that neurons are not programmed for a single task but are actually highly dynamic and agile. Even during such routine tasks as a daily stroll, our brain sometimes needs to shift...

A stay at the Stem Cell Hotel

By Davide Danovi - Director, HipSci Cell Phenotyping Programme, Centre for Stem Cells and Regenerative Medicine, King’s College London All cells in our body came from one original cell - a fertilised egg. A blood...

Is your IP Strategy fit for purpose? – Five Questions to Ask Yourself

As a result of the lockdown due to the global pandemic there is a greater need and renewed focus on using innovation to kick-start the economic recovery. The result is significant investment in R&D...

Adult Vaccination

“Vaccination can provide cost-effective protection against a host of diseases throughout life, but remains an underused public-health strategy in adults for the promotion of healthy ageing. Without specific vaccination programmes for the adult population...

‘Biggest’ leap in identified lung health genes paves way for personalised risk score

Over 500 new genes have been linked to lung function for the first time, allowing a better understanding of  lung disease. The study, led by the University of Leicester and University of Nottingham, is the...